Clinical Trial Update: Unrefined Salmon Oil as Dietary Supplement in Patient With Chronic Obstructive Pulmonary Disease [NA]

View source ↗

Summary

A clinical trial investigating unrefined salmon oil as a dietary supplement in patients with chronic obstructive pulmonary disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Unrefined Salmon Oil

Snippet

Sponsor: Hofseth Biocare ASA | Conditions: Chronic Obstructive Pulmonary Disease | NA | Status: WITHDRAWN